COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancerXiaoxia Jiang, Lisong Teng, Kuifeng He et al.|Molecular Medicine Reports|2019Cited by 66
Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathwaysHaiyong Wang, Lisong Teng, Jun Lu et al.|BMC Cancer|2017Cited by 47
Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signalingHaiyong Wang, Zhiqiang Meng|International Journal of Oncology|2018Cited by 46
GPRC5A: An Emerging Biomarker in Human CancerXiaoxia Jiang, Lisong Teng, Haiyong Wang et al.|BioMed Research International|2018Cited by 46
Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signalingHaiyong Wang, Zhiqiang Meng|International Journal of Oncology|2016Cited by 42